Vimarsana
Biggest News Aggregation in the World

Page 6 - Euronext News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Euronext. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Euronext Today - Breaking & Trending Today

Ex-LSE chief Xavier Rolet calls on next government to save struggling stock market - Vimarsana News

Ex-LSE chief Xavier Rolet calls on next government to save struggling stock market

The former chief executive of the London Stock Exchange (LSE) has urged the next government to save the UK’s struggling equities market as he warned of a bleak future for the City without additional support.

Source: yahoo.com
Schulz Wealth LTD. Invests $338,000 in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP) - Vimarsana News

Schulz Wealth LTD. Invests $338,000 in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP)

Schulz Wealth LTD. acquired a new position in shares of Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,140 shares of the company’s stock, valued at approximately $338,000. A number of other hedge […]

Schulz Wealth LTD. Takes $338,000 Position in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP) - Vimarsana News

Schulz Wealth LTD. Takes $338,000 Position in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP)

Schulz Wealth LTD. purchased a new stake in shares of Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 2,140 shares of the company’s stock, valued at approximately $338,000. Several other large investors have also […]

Source: wkrb13.com
Dupixent (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD - Vimarsana News

Dupixent (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD

31.05.2024 - Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved lung function If approved, ...

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD - Vimarsana News

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD

Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved...